Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Actinium Makes New Appointments

This article was originally published in Scrip

Executive Summary

Actinium Pharmaceuticals, Inc. has appointed Kevin Zikaras senior clinical scientist and Rowena Choudrie senior director, pharmaceutical product development. Zikaras joins Actinium from Bristol-Myers Squibb where he was clinical protocol manager in the immuno-oncology group and prior to this he was clinical research manager at Columbia University Medical Center. Choudrie has over 20 years' experience in the pharma industry and most recently was senior director, pharma development, global technical operations at NPS Pharmaceuticals. Previously, she worked at Palatin Technologies, Inc. as director, formulation development and manufacturing.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst